Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CYTRX CORP | 180,000 | reported | 10 Dec 2013 | tx 27+806,098−25,769 |
| Imunon, Inc. | 109,162 | reported | 20 Jun 2014 | tx 45+786,291.33−105,360 |
| Sintx Technologies, Inc. | 77,069 | reported | 12 Aug 2014 | tx 7+64,848−618,334 |
| DISCOVERY LABORATORIES INC /DE/ | 60,000 | reported | 08 Jun 2012 | tx 16+416,800 |
| HUMAN GENOME SCIENCES INC | 27,699 | reported | 11 Apr 2008 | tx 7+50,699 |
| BIOSPECIFICS TECHNOLOGIES CORP | 15,000 | reported | 04 Aug 2014 | tx 1+15,000 |
| COLUMBIA LABORATORIES INC | 12,000 | reported | 12 May 2004 | tx 3+25,000−13,000 |
| PROTEIN DESIGN LABS INC/DE | 5,000 | reported | 30 Nov 2006 | tx 24+171,000−20,000 |
| ALEXION PHARMACEUTICALS INC | 2,785 | reported | 05 May 2014 | tx 61+316,265−426,423 |
| CELL THERAPEUTICS INC | 0 | reported | 25 Sept 2003 | tx 2+15,000−15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Aug 2014 | GRANT_AWARD | Sintx Technologies, Inc. | 6,984 | 0.00 USD | |
| 04 Aug 2014 | GRANT_AWARD | BIOSPECIFICS TECHNOLOGIES CORP | 15,000 | 0.00 USD | deriv |
| 20 Jun 2014 | GRANT_AWARD | Imunon, Inc. | 40,000 | 0.00 USD | deriv |
| 05 May 2014 | GRANT_AWARD | ALEXION PHARMACEUTICALS INC | 2,785 | 159.70 USD | deriv |
| 28 Feb 2014 | GRANT_AWARD | ALEXION PHARMACEUTICALS INC | 895 | 0.00 USD | |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 57,864 | — | |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 125,000 | 0.00 USD | deriv |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 35,000 | 0.00 USD | deriv |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 333,334 | 0.00 USD | deriv |
| 19 Feb 2014 | CONVERSION | Sintx Technologies, Inc. | 25,000 | 0.00 USD | deriv |
| 11 Feb 2014 | GRANT_AWARD | Imunon, Inc. | 14,000 | 0.00 USD | deriv |
| 03 Feb 2014 | SALE | ALEXION PHARMACEUTICALS INC | 3,000 | 157.09 USD | |
| 03 Feb 2014 | SALE | ALEXION PHARMACEUTICALS INC | 13,912 | 155.91 USD | |
| 03 Feb 2014 | SALE | ALEXION PHARMACEUTICALS INC | 10,662 | 154.95 USD | |
| 03 Feb 2014 | SALE | ALEXION PHARMACEUTICALS INC | 12,426 | 154.02 USD | |
| 10 Dec 2013 | GRANT_AWARD | CYTRX CORP | 180,000 | 0.00 USD | deriv |
| 07 May 2013 | GRANT_AWARD | ALEXION PHARMACEUTICALS INC | 3,425 | 0.00 USD | deriv |
| 06 May 2013 | GRANT_AWARD | Imunon, Inc. | 45,000 | 0.00 USD | deriv |
| 06 Feb 2013 | GRANT_AWARD | ALEXION PHARMACEUTICALS INC | 2,471 | 0.00 USD | |
| 10 Dec 2012 | GRANT_AWARD | CYTRX CORP | 100,000 | 0.00 USD | deriv |
| 10 Dec 2012 | PURCHASE | Imunon, Inc. | 14,000 | 7.60 USD | |
| 20 Sept 2012 | EXERCISE | Imunon, Inc. | 18,735 | 4.22 USD | |
| 20 Sept 2012 | EXERCISE | Imunon, Inc. | 17,083 | 3.25 USD | |
| 20 Sept 2012 | EXERCISE | Imunon, Inc. | 34,542 | 2.77 USD |
3 purchases reported after at least 12 months of silence — most recent on 14 Jan 2011.